Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers

Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers

Nov 20, 2020
|
Ciara Curtin
Premium

NEW YORK — As whole-genome sequencing becomes a more common testing option, a panel of genetic counselors and others participating in the virtual annual meeting of the National Society of Genetic Counselors this week discussed whether healthcare providers and payors are ready for its use as a first-line test.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Vaccine Authorization

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

Healthcare Workers, Nursing Home Residents First

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

Hackers Target Vaccine Makers

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

Cell Studies on Months-Long SARS-CoV-2 Shedding, Spike Mutation, Ebola Infection Dynamics

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.

Dec
10
Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Featured Webinar

Five Things to Consider When Ordering NIPT

Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms. 

What's Popular?

In Sequencing

  1. Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

  2. China NMPA Approves Illumina NextSeq 550Dx Sequencer for Genetic Testing and Diagnosis

  3. Nonalcoholic Fatty Liver Disease Progression Can Be Traced by Gene Expression Signature

  4. Depression-Related Gut Microbiome, Metabolite Changes Lead to Potential Biomarker Set

  5. Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.